Novel respiratory cell changes identified from cigarette smoke exposure

December 11, 2019

(Boston)--Cigarette smoking changes the types of cells that are present in the respiratory track and some biological processes necessary for detoxification of cigarette smoke are restricted to specific types of cells.

"Our study describes novel respiratory cell changes that result from cigarette smoke exposure that may be associated with the development of pre-cancerous tissue," explained corresponding author Jennifer Beane, PhD, assistant professor of medicine at Boston University School of Medicine. Specifically, the researchers have identified a novel type of cell present in current smokers that remains active even after smoking cessation. Gene expressed by these cells have also been detected in both pre-cancerous lung tissue and lung tumors. Further study of these cells may result in therapies to prevent the development of lung cancer or ways to measure risk of developing lung cancer.

Cigarette smoking is a major risk factor for the development of lung cancer. Lung cancer is the leading cause of cancer death in the U.S. While studies have shown that smoking alters bronchial epithelial function and form, its precise effects on specific cell types and overall tissue composition have been unclear.

Never and current smokers underwent a medical procedure called a bronchoscopy to collect cells from their respiratory tract. Lead author, Grant Duclos, explains "Using a breakthrough approach referred to as ;single-cell genomics', the cells sampled from each subject were isolated and the expression of their genes were measured to identify distinct types of cells and characterize differences in the distribution of the cells between never and current smokers." The results were then confirmed by looking at these differences in tissue sampled from additional never and current smokers.

The researchers believe that a detailed understanding of the molecular consequences of drivers of deadly lung diseases - smoking in particular - will enable them to understand the transition from healthy, normal states to pathological conditions. "We hope that this study and the work that follows it will lead to effective strategies for early detection, prevention and reversal of smoking-associated lung diseases," added co-corresponding author Joshua Campbell, PhD, assistant professor of medicine at BUSM.

These finding appear in the journal Science Advances.
-end-
Additional BUSM authors were: Grant E. Duclos, BS; Robert Terrano, MPH,: Yves M. Dumas, MSN,: Gang Liu, PhD; Sarah A. Mazzilli, PhD; Marc E. Lenburg PhD, and Avrum Spira, MD, MSc

Funding for this study was provided by the Department of Defense grant W81XWH14-1-0234 (J.B.). J.B. and J.C. were supported by the LUNGevity Career Development Award. G.D. was supported by the NIH T32 training grant HL007035. S.J. is a Wellcome Trust Senior Fellow in Clinical Science and is supported by the Rosetrees Trust and UCLH Charitable Foundation. V.T. and S.J. are funded by the Roy Castle Lung Cancer Foundation. This work was partially undertaken at UCLH/UCL, which received funding from the UK Department of Health's NIHR Biomedical Research 10 Centre's funding scheme (S.J.).

Boston University School of Medicine

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.